IP Library Assignment 037163/0890
Patent Assignment
Reel/Frame 037163/0890

Change of Address

Recorded: 2015-11-30 Pages: 3
Assignor
Assignee
MITSUBISHI TANABE PHARMA CORPORATION
3-2-10, DOSHO-MACHI, CHUO-KU, OSAKI-SHI, 541-8505, JAPAN
Covered Properties (7)
Glucopyranoside Compound
Patent: 7,943,788 →
Application: 11/045,446 →
Publication: US 2005/0233988
Crystalline Form of 1-(B-D-Glucopyransoyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2- Thienylmethyl]Benzene Hemihydrate
Patent: 7,943,582 →
Application: 11/987,670 →
Publication: US 2008/0146515
Glucopyranoside Compound
Patent: 8,202,984 →
Application: 13/005,757 →
Publication: US 2011/0105424
Crystalline Form of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]Benzene Hemihydrate
Patent: 8,513,202 →
Application: 13/103,557 →
Publication: US 2011/0212905
Glucopyranoside Compound
Patent: 8,222,219 →
Application: 13/174,814 →
Publication: US 2012/0058941
Glucopyranoside Compound
Patent: 8,785,403 →
Application: 13/494,602 →
Publication: US 2012/0258913
Glucopyranoside Compound
Application: 14/299,470 →
Publication: US 2014/0296506
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 28, 2005
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI; UETA, KIICHIRO
To: TANABE SEIYAKU CO., LTD.
Reel/Frame 016731/0161 →
Change of Name Oct 26, 2007
From: TANABE SEIYAKU CO., LTD.
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020021/0001 →
Assignment of Assignor's Interest Mar 3, 2008
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020588/0269 →
Corrective Assignment to Correct the Address of Assignee Previously Recorded on Reel 037163 Frame 0890. Assignor(S) Hereby Confirms the Correct Address Is as Follows: 3-2-10, Dosho-Machi, Chuo-Ku, Osaka-Shi, Osaka, 541-8505 Japan. Dec 21, 2015
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037354/0934 →
Change of Name Mar 5, 2026
From: MITSUBISHI TANABE PHARMA CORPORATION
To: TANABE PHARMA CORPORATION
Reel/Frame 073977/0840 →